Cancer Immune Responsiveness Workshop

Starts:  Sep 4, 2019 08:00 (CT)
Ends:  Sep 5, 2019 12:55 (CT)

Sept. 4, 8 a.m. – 6 p.m. | Sept. 5, 8 a.m. – 12:55 p.m.*

*Lunch will be available until 2 p.m. Thursday following the workshop.


Alessandra Cesano, MD, PhD – ESSA Pharma Inc.
Francesco M. Marincola, MD – Refuge Biotechnologies, Inc.

Building upon the success of 2018's Interim Workshop on Cancer Immune Responsiveness (CIR), the goal of this year's CIR workshop is the continued advancement of knowledge in the field about interactions between the immune system and cancer that contribute to immunotherapy response and resistance.

Over this two-day workshop, participants will take part in both didactic sessions and working groups to identify and address key questions in the field concerning cancer immune responsiveness.

Topics to be discussed include:

  • The role of host genetics and epigenetics in immune responsiveness
  • Transcription patterns indicative of distinct tumor immune landscapes
  • Novel therapeutic strategies and related analytical approaches that involve modification of the tumor microenvironment
  • Circumstantial/environmental factors that may help determine the immunological constant of rejection in the context of cancer
Attendee participation will greatly assist in defining and expanding upon pivotal questions concerning mechanisms of cancer immune responsiveness/resistance in order to advance improved therapeutic strategies and patient benefit with immunotherapy. It is anticipated that the efforts of numerous attendee-driven working groups will further momentum in the field by continuing discussions aimed at addressing the critical questions generated within this workshop well into the future.



Royal Sonesta Houston
2222 West South Loop
Houston, TX 77027